Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin Prophylaxis for Prelabor Cesarean Delivery
NCT06605118Phase 3Recruiting
- Sponsor
- George Washington University Biostatistics Center
- Start
- Nov 2024
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Post-cesarean infection comparing Azithromycin prophylaxis with Placebo (2 arms). Primary endpoint: Maternal infection composite at 6 weeks. Started Nov 2024; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Post-cesarean infection
Beyond the preview
Go deeper on NCT06605118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605118.